Trial design and baseline data for LIRA‐PRIME: A randomized trial investigating the efficacy of liraglutide in controlling glycaemia in type 2 diabetes in a primary care setting

AIMS: Using a pragmatic approach, the LIRA‐PRIME trial aims to address a knowledge gap by comparing efficacy in controlling glycaemia with glucagon‐like peptide‐1 analog liraglutide vs oral antidiabetic drugs (OADs) in patients with type 2 diabetes (T2D) uncontrolled with metformin monotherapy in pr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes Obes Metab
Autors principals: Unger, Jeff, Allison, Dale C., Carlton, Melissa, Lakkole, Kavitha, Lowe, Derek, Murphy, Gerri, Panda, Jayant K., Sargin, Mehmet, Kaltoft, Margit, Treppendahl, Marianne B., Zoghbi, Marouan
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Ltd 2019
Matèries:
Clinical Trial Design
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6617804/
https://ncbi.nlm.nih.gov/pubmed/30828917
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13682
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars